Eligibility
18+
All Sexes
What conditions do you have?
Select
Study Summary
This study is evaluating whether there is a previously unrecognized metabolic pathway between two prostaglandins.
Treatment Effectiveness
Effectiveness Progress
Other trials for Bleomycin B2
Study Objectives
1 Primary · 0 Secondary · Reporting Duration: 0-10 hours
0-10 hours
prostaglandin metabolites
Trial Safety
Safety Progress
Other trials for Bleomycin B2
Trial Design
4 Treatment Groups
deuterated PGD2
1 of 4
niacin + low-dose aspirin
1 of 4
niacin
1 of 4
niacin + regular-strength aspirin
1 of 4
Experimental Treatment
10 Total Participants · 4 Treatment Groups
Primary Treatment: PGD2 · No Placebo Group · Phase < 1
deuterated PGD2
Other
Experimental Group · 1 Intervention: PGD2 · Intervention Types: Otherniacin + low-dose aspirinExperimental Group · 2 Interventions: niacin, aspirin · Intervention Types: DietarySupplement, Drug
niacin
DietarySupplement
Experimental Group · 1 Intervention: niacin · Intervention Types: DietarySupplementniacin + regular-strength aspirinExperimental Group · 2 Interventions: niacin, aspirin · Intervention Types: DietarySupplement, Drug
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
niacin
2003
Completed Phase 4
~390
Acetylsalicylic acid
FDA approved
Trial Logistics
Trial Timeline
Approximate Timeline
Screening: ~3 weeks
Treatment: Varies
Reporting: 0-10 hours
Who is running the clinical trial?
Vanderbilt University Medical CenterOTHER
768 Previous Clinical Trials
592,104 Total Patients Enrolled
Vanderbilt UniversityLead Sponsor
682 Previous Clinical Trials
6,131,386 Total Patients Enrolled
Claus M Schneider, PhDPrincipal InvestigatorVanderbilt University
Eligibility Criteria
Age 18+ · All Participants · 1 Total Inclusion Criteria
Mark “yes” if the following statements are true for you:About The Reviewer
Michael Gill holds a Bachelors of Science in Integrated Science and Mathematics from McMaster University. During his degree he devoted considerable time modeling the pharmacodynamics of promising drug candidates. Since then, he has leveraged this knowledge of the investigational new drug ecosystem to help his father navigate clinical trials for multiple myeloma, an experience which prompted him to co-found Power Life Sciences: a company that helps patients access randomized controlled trials.
Popular Clinical Trials
Top Clinical Trials in Cities
Relevant Clinical Trials
Unbiased Results
We believe in providing patients with all the options.Your Data Stays Your Data
We only share your information with the clinical trials you're trying to access.Verified Trials Only
All of our trials are run by licensed doctors, researchers, and healthcare companies.Back to top
Conditions
Cancer Related
Treatments